Combined use of clopidogrel and atorvastatin for angina pectoris caused by coronary heart disease: clinical effectiveness, safety, and contributing factors
{{output}}
Objective: To evaluate the combined use of Clopidogrel (CLO) and Atorvastatin (ATO) in patients with angina pectoris caused by coronary heart disease (CHD-AP), focusing on clinical effectiveness, safety, and contributing factors.... ...
